Minimally invasive prostate cancer treatment shows success in first patient

Bill Faulkner had long approached prostate cancer testing with skepticism. For almost a decade, the 73-year-old had avoided the prostate-specific antigen test because of concerns about over-diagnosis; over-treatment; and, most of all, the potentially life-altering side effects of invasive surgical treatments.

Leave A Comment

Your email address will not be published. Required fields are marked *